QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 6 filers reported holding QIAGEN NV in Q1 2017. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $5,261,000 | +19.1% | 156,900 | +2.9% | 2.09% | +59.8% |
| Q1 2017 | $4,418,000 | +103.1% | 152,500 | +93.9% | 1.31% | +42.4% |
| Q4 2015 | $2,175,000 | -0.8% | 78,668 | -7.4% | 0.92% | -26.7% |
| Q3 2015 | $2,193,000 | -21.6% | 85,000 | -15.0% | 1.25% | -12.6% |
| Q2 2015 | $2,798,000 | – | 100,000 | – | 1.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hardman Johnston Global Advisors LLC | 6,178,402 | $170,833,000 | 11.32% |
| Tikvah Management LLC | 369,425 | $10,215,000 | 5.35% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 360,000 | $9,954,000 | 3.36% |
| Opus Point Partners Management, LLC | 160,000 | $4,424,000 | 2.92% |
| Exane Asset Management | 106,238 | $2,910,304,000 | 1.76% |
| Douglas C. Lane & Associates, Inc. | 1,918,338 | $53,042,000 | 1.44% |
| Granahan Investment Management | 1,051,000 | $29,060,000 | 1.00% |
| CRAMER ROSENTHAL MCGLYNN LLC | 2,285,569 | $63,196,000 | 0.95% |
| Sivik Global Healthcare LLC | 70,000 | $1,936,000 | 0.92% |
| PURA VIDA INVESTMENTS, LLC | 78,668 | $2,175,000 | 0.92% |